Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy

NCT00245765 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG: Certolizumab Pegol
OTHER: Placebo

Sponsor

UCB Pharma